| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.41B | +18.4% |
| Cost of Revenue | $744.0M | +14.4% |
| R&D Expense | $333.6M | +7.0% |
| SG&A Expense | $449.9M | +2.7% |
| Operating Income | -$13.65B | -5039.9% |
| Pre-tax Income | -$13.66B | -3452.1% |
| Income Tax | -$3.8M | -108.6% |
| Net Income | -$13.66B | -3085.6% |
| EPS (Basic) | -$84.60 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $918.2M | +2.8% |
| Accounts Receivable | $210.6M | +24.6% |
| Inventory | $56.3M | -22.9% |
| Current Assets | $1.32B | +7.3% |
| Total Assets | $4.35B | -75.5% |
| Current Liabilities | $399.8M | +20.8% |
| Stockholders' Equity | $2.31B | -85.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $189.3M | -2.4% |
| Capital Expenditures | $16.5M | +93.1% |
| Investing Cash Flow | -$167.7M | -129.8% |
| Financing Cash Flow | $6.5M | -84.1% |
| Free Cash Flow | $172.8M | -6.8% |
| -2998.9% |
| EPS (Diluted) | -$84.60 | -2998.9% |